Aaron Mann is the Chief Executive Officer of Kindeva Drug Delivery and was previously President and General Manager of 3M Drug Delivery Systems. He holds a BA in Economics from Carleton College and an MBA from the
Harvard Business School.
In this exclusive interview with ONdrugDelivery, Aaron Mann discusses how Kindeva is positioned to move forward as a major CDMO specialising in inhalation and transdermal dosage forms, having been formed from 3M’s drug delivery in May 2020. We also cover the impact of Covid-19, environmental sustainability, and current challenges faced by the pharmaceutical industry.